0 XP   0   0   0

ALPA LABORATORIES LTD.
Buy, Hold or Sell?

Should you buy, hold or sell ALPA LABORATORIES LTD.?

I guess you are interested in ALPA LABORATORIES LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse ALPA LABORATORIES LTD.

Let's start. I'm going to help you getting a better view of ALPA LABORATORIES LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is ALPA LABORATORIES LTD. even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how ALPA LABORATORIES LTD. is doing in the market. If the company is worth buying. The latest step is to find out how other investors value ALPA LABORATORIES LTD.. The closing price on 2023-01-30 was INR62.65 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
ALPA LABORATORIES LTD. Daily Candlestick Chart
ALPA LABORATORIES LTD. Daily Candlestick Chart
Summary









1. Valuation of ALPA LABORATORIES LTD.




Current price per share

INR62.65

2. Growth of ALPA LABORATORIES LTD.




Is ALPA LABORATORIES LTD. growing?

Current yearPrevious yearGrowGrow %
How rich?$14.9m$13.2m$1.7m11.6%

How much money is ALPA LABORATORIES LTD. making?

Current yearPrevious yearGrowGrow %
Making money$1.7m$891.3k$841.9k48.6%
Net Profit Margin12.6%7.4%--

How much money comes from the company's main activities?

3. Financial Health of ALPA LABORATORIES LTD.




Comparing to competitors in the Pharmaceuticals industry




  Industry Rankings (Pharmaceuticals)  


Richest
#31 / 54

Most Revenue
#32 / 54

Most Profit
#27 / 54


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of ALPA LABORATORIES LTD..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit ALPA LABORATORIES LTD. earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare ALPA LABORATORIES LTD. to the Pharmaceuticals industry mean.
  • A Net Profit Margin of 12.6% means that ₹0.13 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of ALPA LABORATORIES LTD.:

  • The MRQ is 12.6%. The company is making a huge profit. +2
  • The TTM is 12.6%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ12.6%TTM12.6%0.0%
TTM12.6%YOY7.4%+5.1%
TTM12.6%5Y5.6%+7.0%
5Y5.6%10Y5.3%+0.3%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ12.6%3.3%+9.3%
TTM12.6%6.9%+5.7%
YOY7.4%9.9%-2.5%
5Y5.6%6.3%-0.7%
10Y5.3%6.7%-1.4%
1.1.2. Return on Assets

Shows how efficient ALPA LABORATORIES LTD. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare ALPA LABORATORIES LTD. to the Pharmaceuticals industry mean.
  • 9.1% Return on Assets means that ALPA LABORATORIES LTD. generated ₹0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of ALPA LABORATORIES LTD.:

  • The MRQ is 9.1%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 9.1%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ9.1%TTM9.1%0.0%
TTM9.1%YOY5.2%+3.9%
TTM9.1%5Y3.8%+5.3%
5Y3.8%10Y3.5%+0.3%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ9.1%0.8%+8.3%
TTM9.1%1.3%+7.8%
YOY5.2%1.5%+3.7%
5Y3.8%1.4%+2.4%
10Y3.5%1.4%+2.1%
1.1.3. Return on Equity

Shows how efficient ALPA LABORATORIES LTD. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare ALPA LABORATORIES LTD. to the Pharmaceuticals industry mean.
  • 11.6% Return on Equity means ALPA LABORATORIES LTD. generated ₹0.12 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of ALPA LABORATORIES LTD.:

  • The MRQ is 11.6%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 11.6%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ11.6%TTM11.6%0.0%
TTM11.6%YOY6.7%+4.8%
TTM11.6%5Y4.8%+6.8%
5Y4.8%10Y4.5%+0.4%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ11.6%1.5%+10.1%
TTM11.6%2.0%+9.6%
YOY6.7%3.0%+3.7%
5Y4.8%2.1%+2.7%
10Y4.5%2.0%+2.5%

1.2. Operating Efficiency of ALPA LABORATORIES LTD..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient ALPA LABORATORIES LTD. is operating .

  • Measures how much profit ALPA LABORATORIES LTD. makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare ALPA LABORATORIES LTD. to the Pharmaceuticals industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of ALPA LABORATORIES LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y2.2%-2.2%
5Y2.2%10Y3.5%-1.3%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ--5.6%+5.6%
TTM-0.5%-0.5%
YOY-6.2%-6.2%
5Y2.2%5.1%-2.9%
10Y3.5%5.2%-1.7%
1.2.2. Operating Ratio

Measures how efficient ALPA LABORATORIES LTD. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • An Operation Ratio of 1.58 means that the operating costs are ₹1.58 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of ALPA LABORATORIES LTD.:

  • The MRQ is 1.577. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.577. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.577TTM1.5770.000
TTM1.577YOY1.552+0.025
TTM1.5775Y1.401+0.176
5Y1.40110Y1.272+0.129
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5771.342+0.235
TTM1.5771.276+0.301
YOY1.5521.169+0.383
5Y1.4011.149+0.252
10Y1.2721.178+0.094

1.3. Liquidity of ALPA LABORATORIES LTD..

1.3. Liquidity
1.3.1. Current Ratio

Measures if ALPA LABORATORIES LTD. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A Current Ratio of 4.43 means the company has ₹4.43 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of ALPA LABORATORIES LTD.:

  • The MRQ is 4.427. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.427. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.427TTM4.4270.000
TTM4.427YOY3.726+0.702
TTM4.4275Y4.229+0.198
5Y4.22910Y4.111+0.118
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ4.4272.205+2.222
TTM4.4272.010+2.417
YOY3.7262.125+1.601
5Y4.2291.812+2.417
10Y4.1111.786+2.325
1.3.2. Quick Ratio

Measures if ALPA LABORATORIES LTD. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare ALPA LABORATORIES LTD. to the Pharmaceuticals industry mean.
  • A Quick Ratio of 6.04 means the company can pay off ₹6.04 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of ALPA LABORATORIES LTD.:

  • The MRQ is 6.038. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 6.038. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ6.038TTM6.0380.000
TTM6.038YOY4.323+1.715
TTM6.0385Y4.961+1.077
5Y4.96110Y4.650+0.311
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ6.0381.118+4.920
TTM6.0381.152+4.886
YOY4.3231.091+3.232
5Y4.9611.007+3.954
10Y4.6500.869+3.781

1.4. Solvency of ALPA LABORATORIES LTD..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of ALPA LABORATORIES LTD. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare ALPA LABORATORIES LTD. to Pharmaceuticals industry mean.
  • A Debt to Asset Ratio of 0.22 means that ALPA LABORATORIES LTD. assets are financed with 21.6% credit (debt) and the remaining percentage (100% - 21.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of ALPA LABORATORIES LTD.:

  • The MRQ is 0.216. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.216. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.216TTM0.2160.000
TTM0.216YOY0.233-0.017
TTM0.2165Y0.201+0.015
5Y0.20110Y0.209-0.007
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2160.381-0.165
TTM0.2160.379-0.163
YOY0.2330.417-0.184
5Y0.2010.398-0.197
10Y0.2090.399-0.190
1.4.2. Debt to Equity Ratio

Measures if ALPA LABORATORIES LTD. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare ALPA LABORATORIES LTD. to the Pharmaceuticals industry mean.
  • A Debt to Equity ratio of 27.5% means that company has ₹0.28 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of ALPA LABORATORIES LTD.:

  • The MRQ is 0.275. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.275. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.275TTM0.2750.000
TTM0.275YOY0.304-0.029
TTM0.2755Y0.253+0.022
5Y0.25310Y0.265-0.012
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2750.586-0.311
TTM0.2750.598-0.323
YOY0.3040.598-0.294
5Y0.2530.671-0.418
10Y0.2650.664-0.399

2. Market Valuation of ALPA LABORATORIES LTD.

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings ALPA LABORATORIES LTD. generates.

  • Above 15 is considered overpriced but always compare ALPA LABORATORIES LTD. to the Pharmaceuticals industry mean.
  • A PE ratio of 11.86 means the investor is paying ₹11.86 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of ALPA LABORATORIES LTD.:

  • The EOD is 9.354. Very good. +2
  • The MRQ is 11.855. Very good. +2
  • The TTM is 11.855. Very good. +2
Trends
Current periodCompared to+/- 
EOD9.354MRQ11.855-2.501
MRQ11.855TTM11.8550.000
TTM11.855YOY10.481+1.374
TTM11.8555Y25.513-13.657
5Y25.51310Y25.512+0.001
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD9.35440.785-31.431
MRQ11.85551.661-39.806
TTM11.85551.419-39.564
YOY10.48164.495-54.014
5Y25.51356.903-31.390
10Y25.51261.712-36.200
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of ALPA LABORATORIES LTD..

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of ALPA LABORATORIES LTD.:

  • The MRQ is 6.097. Seems overpriced? -1
  • The TTM is 6.097. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ6.097TTM6.0970.000
TTM6.097YOY2.681+3.416
TTM6.0975Y39.520-33.423
5Y39.52010Y39.5200.000
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ6.0970.015+6.082
TTM6.0970.036+6.061
YOY2.6810.327+2.354
5Y39.5200.144+39.376
10Y39.5200.144+39.376

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of ALPA LABORATORIES LTD. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A PB ratio of 1.37 means the investor is paying ₹1.37 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of ALPA LABORATORIES LTD.:

  • The EOD is 1.083. Good. +1
  • The MRQ is 1.372. Good. +1
  • The TTM is 1.372. Good. +1
Trends
Current periodCompared to+/- 
EOD1.083MRQ1.372-0.290
MRQ1.372TTM1.3720.000
TTM1.372YOY0.706+0.667
TTM1.3725Y0.782+0.590
5Y0.78210Y0.765+0.017
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD1.0832.248-1.165
MRQ1.3722.690-1.318
TTM1.3723.050-1.678
YOY0.7063.185-2.479
5Y0.7822.899-2.117
10Y0.7652.711-1.946
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of ALPA LABORATORIES LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--6.6976.6970%3.455+94%2.567+161%9.643-31%
Book Value Growth--1.1311.1310%1.072+5%1.052+7%1.052+7%
Book Value Per Share--57.85557.8550%51.159+13%49.978+16%49.152+18%
Book Value Per Share Growth--1.1311.1310%1.072+5%1.052+7%1.052+7%
Current Ratio--4.4274.4270%3.726+19%4.229+5%4.111+8%
Debt To Asset Ratio--0.2160.2160%0.233-7%0.201+7%0.209+3%
Debt To Equity Ratio--0.2750.2750%0.304-9%0.253+9%0.265+4%
Dividend Per Share----0%-0%-0%-0%
Eps--6.6976.6970%3.444+94%2.567+161%2.339+186%
Eps Growth--1.9441.9440%3.910-50%1.832+6%1.832+6%
Free Cash Flow Per Share---0.010-0.0100%-2.333+24447%-0.647+6703%0.695-101%
Free Cash Flow Per Share Growth--1.9961.9960%-0.322+116%2.162-8%2.162-8%
Free Cash Flow To Equity Per Share--2.6502.6500%-2.245+185%0.160+1556%0.161+1545%
Free Cash Flow To Equity Per Share Growth--3.1803.1800%-0.340+111%-1.831+158%-1.831+158%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---0.372--------
Intrinsic Value_10Y_min---0.310--------
Intrinsic Value_1Y_max---0.016--------
Intrinsic Value_1Y_min---0.015--------
Intrinsic Value_3Y_max---0.063--------
Intrinsic Value_3Y_min---0.059--------
Intrinsic Value_5Y_max---0.131--------
Intrinsic Value_5Y_min---0.119--------
Net Profit Margin--0.1260.1260%0.074+69%0.056+125%0.053+136%
Operating Margin----0%-0%0.022-100%0.035-100%
Operating Ratio--1.5771.5770%1.552+2%1.401+13%1.272+24%
Pb Ratio1.083-27%1.3721.3720%0.706+94%0.782+75%0.765+79%
Pe Ratio9.354-27%11.85511.8550%10.481+13%25.513-54%25.512-54%
Peg Ratio--6.0976.0970%2.681+127%39.520-85%39.520-85%
Price Per Share62.650-27%79.40079.4000%36.100+120%40.250+97%38.633+106%
Price To Total Gains Ratio9.356-27%11.85711.8570%10.450+13%26.186-55%21.935-46%
Profit Growth--1.9451.9450%3.910-50%1.832+6%1.832+6%
Quick Ratio--6.0386.0380%4.323+40%4.961+22%4.650+30%
Return On Assets--0.0910.0910%0.052+76%0.038+140%0.035+160%
Return On Equity--0.1160.1160%0.067+72%0.048+141%0.045+160%
Revenue Growth--1.1511.1510%1.135+1%1.124+2%1.124+2%
Total Gains Per Share--6.6976.6970%3.455+94%2.567+161%9.643-31%
Total Gains Per Share Growth--1.9381.9380%3.870-50%1.632+19%1.632+19%
Usd Book Value--14972937.60014972937.6000%13239879.900+13%12934397.100+16%12720629.250+18%
Usd Book Value Change Per Share--0.0820.0820%0.042+94%0.032+161%0.119-31%
Usd Book Value Per Share--0.7120.7120%0.629+13%0.615+16%0.605+18%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.0820.0820%0.042+94%0.032+161%0.029+186%
Usd Free Cash Flow---2460.000-2460.0000%-603843.900+24447%193538.040-101%161281.700-102%
Usd Free Cash Flow Per Share--0.0000.0000%-0.029+24447%-0.008+6703%0.009-101%
Usd Free Cash Flow To Equity Per Share--0.0330.0330%-0.028+185%0.002+1556%0.002+1545%
Usd Price Per Share0.771-27%0.9770.9770%0.444+120%0.495+97%0.475+106%
Usd Profit--1733291.4001733291.4000%891381.000+94%664463.220+161%605379.350+186%
Usd Revenue--13808767.20013808767.2000%11999154.300+15%10740960.240+29%10251525.200+35%
Usd Total Gains Per Share--0.0820.0820%0.042+94%0.032+161%0.119-31%
 EOD+3 -2MRQTTM+0 -0YOY+30 -85Y+30 -910Y+24 -15

3.2. Fundamental Score

Let's check the fundamental score of ALPA LABORATORIES LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-159.354
Price to Book Ratio (EOD)Between0-11.083
Net Profit Margin (MRQ)Greater than00.126
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than16.038
Current Ratio (MRQ)Greater than14.427
Debt to Asset Ratio (MRQ)Less than10.216
Debt to Equity Ratio (MRQ)Less than10.275
Return on Equity (MRQ)Greater than0.150.116
Return on Assets (MRQ)Greater than0.050.091
Total7/10 (70.0%)

3.3. Technical Score

Let's check the technical score of ALPA LABORATORIES LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose63.000
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2021-12-31. Currency in INR. All numbers in thousands.

Summary
Total Assets1,552,390
Total Liabilities335,078
Total Stockholder Equity1,217,312
 As reported
Total Liabilities 335,078
Total Stockholder Equity+ 1,217,312
Total Assets = 1,552,390

Assets

Total Assets1,552,390
Total Current Assets1,389,411
Long-term Assets1,389,411
Total Current Assets
Cash And Cash Equivalents 15,752
Short-term Investments 749,424
Net Receivables 380,353
Inventory 154,636
Other Current Assets 82,011
Total Current Assets  (as reported)1,389,411
Total Current Assets  (calculated)1,382,176
+/- 7,235
Long-term Assets
Property Plant Equipment 92,162
Goodwill 1,043
Long-term Assets  (as reported)162,982
Long-term Assets  (calculated)93,205
+/- 69,777

Liabilities & Shareholders' Equity

Total Current Liabilities313,834
Long-term Liabilities21,244
Total Stockholder Equity1,217,312
Total Current Liabilities
Short-term Debt 23,443
Short Long Term Debt 37,228
Accounts payable 149,233
Other Current Liabilities 25,707
Total Current Liabilities  (as reported)313,834
Total Current Liabilities  (calculated)235,611
+/- 78,223
Long-term Liabilities
Long term Debt Total 21,246
Long-term Liabilities Other -2
Long-term Liabilities  (as reported)21,244
Long-term Liabilities  (calculated)21,244
+/-0
Total Stockholder Equity
Common Stock210,406
Retained Earnings 1,006,906
Total Stockholder Equity (as reported)1,217,312
Total Stockholder Equity (calculated)1,217,312
+/-0
Other
Capital Stock210,406
Cash and Short Term Investments 765,176
Common Stock Shares Outstanding 21,041
Liabilities and Stockholders Equity 1,552,390
Net Debt 42,722
Net Invested Capital 1,275,786
Net Working Capital 1,075,577



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
1,255,300
1,215,242
1,212,185
1,213,512
1,403,684
1,552,390
1,552,3901,403,6841,213,5121,212,1851,215,2421,255,300
   > Total Current Assets 
1,046,300
977,200
940,874
954,628
1,210,904
1,389,411
1,389,4111,210,904954,628940,874977,2001,046,300
       Cash And Cash Equivalents 
23,800
213,403
1,491
49,747
105,130
15,752
15,752105,13049,7471,491213,40323,800
       Short-term Investments 
87,400
200,575
330,835
416,660
472,797
749,424
749,424472,797416,660330,835200,57587,400
       Net Receivables 
377,245
357,669
377,384
265,849
354,301
380,353
380,353354,301265,849377,384357,669377,245
       Inventory 
130,400
137,230
140,387
125,505
165,598
154,636
154,636165,598125,505140,387137,230130,400
       Other Current Assets 
92,134
302,308
120,471
117,743
107,655
82,011
82,011107,655117,743120,471302,30892,134
   > Long-term Assets 
0
0
269,109
258,782
192,781
162,982
162,982192,781258,782269,10900
       Property Plant Equipment 
51,800
61,216
58,786
72,291
87,312
92,162
92,16287,31272,29158,78661,21651,800
       Goodwill 
60,700
40,450
20,225
0
551
1,043
1,043551020,22540,45060,700
       Intangible Assets 
0
0
-1
0
551
0
05510-100
> Total Liabilities 
308,000
239,751
227,242
209,786
327,271
335,078
335,078327,271209,786227,242239,751308,000
   > Total Current Liabilities 
297,100
233,613
223,128
207,867
325,020
313,834
313,834325,020207,867223,128233,613297,100
       Short-term Debt 
101,600
51,771
10,531
0
0
23,443
23,4430010,53151,771101,600
       Short Long Term Debt 
0
0
12,555
2,193
1,829
37,228
37,2281,8292,19312,55500
       Accounts payable 
139,400
132,736
131,888
136,987
247,311
149,233
149,233247,311136,987131,888132,736139,400
       Other Current Liabilities 
33,663
37,190
62,541
56,638
2,850
25,707
25,7072,85056,63862,54137,19033,663
   > Long-term Liabilities 
0
0
4,113
2,020
2,251
21,244
21,2442,2512,0204,11300
       Long term Debt Total 
4,700
6,137
4,113
1,920
91
21,246
21,246911,9204,1136,1374,700
       Long-term Liabilities Other 
0
0
0
100
0
-2
-20100000
> Total Stockholder Equity
947,300
975,491
984,943
1,003,726
1,076,413
1,217,312
1,217,3121,076,4131,003,726984,943975,491947,300
   Common Stock
210,400
210,406
210,406
210,406
210,406
210,406
210,406210,406210,406210,406210,406210,400
   Retained Earnings 
736,900
215,480
224,932
243,715
866,007
1,006,906
1,006,906866,007243,715224,932215,480736,900
   Accumulated Other Comprehensive Income 000000
   Capital Surplus 000000
   Treasury Stock000000



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue1,122,664
Cost of Revenue-760,871
Gross Profit361,793361,793
 
Operating Income (+$)
Gross Profit361,793
Operating Expense-1,009,721
Operating Income90,044-647,928
 
Operating Expense (+$)
Research Development-
Selling General Administrative119,343
Selling And Marketing Expenses-
Operating Expense1,009,721119,343
 
Net Interest Income (+$)
Interest Income1,070
Interest Expense-1,069
Net Interest Income12,6251
 
Pretax Income (+$)
Operating Income90,044
Net Interest Income12,625
Other Non-Operating Income Expenses-
Income Before Tax (EBT)195,62090,044
EBIT - interestExpense = -1,069
140,918
141,987
Interest Expense1,069
Earnings Before Interest and Taxes (ebit)-196,689
Earnings Before Interest and Taxes (ebitda)213,289
 
After tax Income (+$)
Income Before Tax195,620
Tax Provision-54,702
Net Income From Continuing Ops140,918140,918
Net Income140,918
Net Income Applicable To Common Shares140,917
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--12,625
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
BYS.SW
4 minutes ago

I found you a Golden Cross on the daily chart of BYS.SW.

BYS.SW Daily Candlestick Chart
ASRUSA.SW
4 minutes ago

I found you a Golden Cross on the daily chart of ASRUSA.SW.

ASRUSA.SW Daily Candlestick Chart
TRAD.ST
5 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TRAD.ST.

TRAD.ST Daily Candlestick Chart
MLAIU.NASDAQ
6 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MLAIU.NASDAQ.

MLAIU.NASDAQ Daily Candlestick Chart
BRKHU.NASDAQ
7 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of BRKHU.NASDAQ.

BRKHU.NASDAQ Daily Candlestick Chart
SPXNTR.INDX
10 minutes ago

I found you a Golden Cross on the daily chart of SPXNTR.INDX.

SPXNTR.INDX Daily Candlestick Chart
SP500NTR.INDX
10 minutes ago

I found you a Golden Cross on the daily chart of SP500NTR.INDX.

SP500NTR.INDX Daily Candlestick Chart
S5TW.INDX
11 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of S5TW.INDX.

S5TW.INDX Daily Candlestick Chart
NDTW.INDX
12 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of NDTW.INDX.

NDTW.INDX Daily Candlestick Chart
AVLD.INDX
17 minutes ago

I found you a MACD Bearish Reversal Divergence on the daily chart of AVLD.INDX.

AVLD.INDX Daily Candlestick Chart
ADVQ.INDX
17 minutes ago

I found you a Death Cross on the daily chart of ADVQ.INDX.

ADVQ.INDX Daily Candlestick Chart
GR1M.GBOND
20 minutes ago

I found you a MACD Bullish Hidden Divergence on the daily chart of GR1M.GBOND.

GR1M.GBOND Daily Candlestick Chart
SBFM.NASDAQ
24 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SBFM.NASDAQ.

SBFM.NASDAQ Daily Candlestick Chart
SANW.NASDAQ
26 minutes ago

I found you a MACD Bullish Hidden Divergence on the daily chart of SANW.NASDAQ.

SANW.NASDAQ Daily Candlestick Chart
RZB.NYSE
27 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of RZB.NYSE.

RZB.NYSE Daily Candlestick Chart
RYU.NYSE ARC
27 minutes ago

I found you a Golden Cross on the daily chart of RYU.NYSE ARC.

RYU.NYSE ARC Daily Candlestick Chart
RRGB.NASDAQ
29 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of RRGB.NASDAQ.

RRGB.NASDAQ Daily Candlestick Chart
RNAZ.NASDAQ
32 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of RNAZ.NASDAQ.

RNAZ.NASDAQ Daily Candlestick Chart
SBITOP.INDX
33 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SBITOP.INDX.

SBITOP.INDX Daily Candlestick Chart
BETXT.INDX
34 minutes ago

I found you a Golden Cross on the daily chart of BETXT.INDX.

BETXT.INDX Daily Candlestick Chart
RGF.NASDAQ
35 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of RGF.NASDAQ.

RGF.NASDAQ Daily Candlestick Chart
REED.NASDAQ
38 minutes ago

I found you a Golden Cross on the daily chart of REED.NASDAQ.

REED.NASDAQ Daily Candlestick Chart
RCUS.NYSE
38 minutes ago

I found you a Death Cross on the daily chart of RCUS.NYSE.

RCUS.NYSE Daily Candlestick Chart
RAIN.NASDAQ
42 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of RAIN.NASDAQ.

RAIN.NASDAQ Daily Candlestick Chart
PZZA.NASDAQ
45 minutes ago

I found you a Golden Cross on the daily chart of PZZA.NASDAQ.

PZZA.NASDAQ Daily Candlestick Chart